Dr. Lal PathLabs Limited Financial Overview
Dr. Lal PathLabs Limited's market cap is currently ₹233.30B. The company's EPS TTM is ₹9; its P/E ratio is 43.46; and it has a dividend yield of 0.90%. Dr. Lal PathLabs Limited is scheduled to report earnings on October 31, 2025, and the estimated EPS forecast is ₹6.84. See an overview of income statement, balance sheet, and cash flow financials.
